Adjuvant hormonal therapy and fertility preservation in premenopausal breast cancer: a survey among Italian oncologists.

about

Adjuvant hormonal therapy and fertility preservation in premenopausal breast cancer: a survey among Italian oncologists.

Item

http://www.wikidata.org/entity/Q39022556

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Adjuvant hormonal therapy and ...... vey among Italian oncologists.

@en

Adjuvant hormonal therapy and ...... vey among Italian oncologists.

@nl

type

Item

label

Adjuvant hormonal therapy and ...... vey among Italian oncologists.

@en

Adjuvant hormonal therapy and ...... vey among Italian oncologists.

@nl

prefLabel

Adjuvant hormonal therapy and ...... vey among Italian oncologists.

@en

Adjuvant hormonal therapy and ...... vey among Italian oncologists.

@nl

P1476

Adjuvant hormonal therapy and ...... rvey among Italian oncologists

@en

P2093

Domenico Amoroso

http://www.w3.org/2001/XMLSchema#string

Elena Collovà

http://www.w3.org/2001/XMLSchema#string

Sandro Barni

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

Cancer statistics, 2004

'An ounce of prevention is worth a pound of cure': the case for and against GnRH-agonist for fertility preservation.

Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist alone in premenopausal advanced breast cancer: a meta-analysis of four randomized trials.

Clinical and endocrine data for goserelin plus anastrozole as second-line endocrine therapy for premenopausal advanced breast cancer.

Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis.

Adjuvant exemestane with ovarian suppression in premenopausal breast cancer.

Side effects of adjuvant treatment of breast cancer.

P304

1181-1189

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/FON.14.289

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Antonio Frassoldati

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25832875

http://www.w3.org/2001/XMLSchema#string